The UK is experiencing a remarkable change in its attitude towards entheogens. What began with a emerging exploration of psilocybin and commonplace Ayahuasca is increasingly broadening to encompass lesser-known substances like copyright and though research into potential uses. This burgeoning interest is fuelled by a combination of research-backed